Repeated Sessions of PACK-CXL WA for the Treatment of Resistant Bacterial Keratitis: a Retrospective Study

Overview

Journal BMC Ophthalmol

Publisher Biomed Central

Specialty Ophthalmology

Date 2023 Jul 26

PMID 37495952

Authors

Mohammed M Mahdy Tawfeek

Hanan Mohamed Abdel Hamid Ahmed

Ashraf Bori

Ahmed M Nashaat Ali Rady

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this work is to evaluate the safety and efficacy of repeated sessions of photo-activated chromophore for keratitis-cross linking (PACK-CXL) window absorption (WA) for the treatment of resistant bacterial keratitis (BK).

Patients And Methods: This is a retrospective clinical cohort study. Thirty eyes with clinically suspected and lab-confirmed bacterial keratitis, resistant to appropriate antibiotic therapy- which was modified by sensitivity reports- for 2 weeks with failure of epithelialization for 4 weeks after the standard anti-microbial therapy (SAT) together with one setting of PACK-CXL WA were included. If after the first session of PACK-CXL, there is a start of improvement in the form of reduction of the size of corneal ulcer and stromal infiltrates together with the start of epithelialization on clinical examination and AS-OCT, another session of PACK-CXL WA was performed after one week, and so on, till the complete healing and resolution of bacterial keratitis and confirmation by negative bacterial culture. Identification of the micro-organisms was done by lab study before and after treatment. Corneal healing was evaluated by corneal examination and anterior segment OCT (AS-OCT).

Results: Thirty eyes of 30 patients were recruited in this study. They were 16 males and 14 females, their mean age was 44.3 ± 5.38 years. The mean ulcer size was 3.96 ± 1.87 (mm), while the mean size of stromal infiltrates was 4.52 ± 2.24 (mm3). PACK-CXL WA treatment was performed an average of 2.87 times for the 30 eyes. Complete healing and resolution (Successful treatment) was observed in 27 eyes (90%) of cases and failure of epithelialization was observed only in 3 eyes (10%). Complete corneal healing was reported in the second month postoperatively in 90% of eyes.

Conclusion And Recommendation: PACK-CXL WA may be a promising, non-invasive treatment option for resistant bacterial keratitis. It may have a synergistic effect with standard antimicrobial treatment (SAT). Also, it can overcome the antibiotics resistance that has become rapidly spreading worldwide. Repeated sessions of PACK-CXL WA may be more effective for the treatment of resistant bacterial keratitis till complete epithelialization and resolution of BK than a single session with few complications. However, further prospective and comparative studies to support the results are needed.

References

Bamdad S, Malekhosseini H, Khosravi A . Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers. Cornea. 2015; 34(4):402-6. DOI: 10.1097/ICO.0000000000000375. View

Papaioannou L, Miligkos M, Papathanassiou M . Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis. Cornea. 2015; 35(1):62-71. DOI: 10.1097/ICO.0000000000000644. View

Gray T, Cursons R, Sherwan J, Rose P . Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases. Br J Ophthalmol. 1995; 79(6):601-5. PMC: 505174. DOI: 10.1136/bjo.79.6.601. View

Rosetta P, Vinciguerra R, Romano M, Vinciguerra P . Corneal collagen cross-linking window absorption. Cornea. 2012; 32(4):550-4. DOI: 10.1097/ICO.0b013e318259c9bb. View

Chan C, Holland E . Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea. 2012; 31(10):1128-34. DOI: 10.1097/ICO.0b013e318245c02a. View

Chew S, Beuerman R, Assouline M, Kaufman H, Barron B, Hill J . Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J. 1992; 18(3):197-201. View

Bori A, El-Haig W . Combined Photoactivated Chromophore for Infectious Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) and Therapeutic Penetrating Keratoplasty for Resistant Bacterial Keratitis. Clin Ophthalmol. 2022; 16:273-279. PMC: 8820449. DOI: 10.2147/OPTH.S348835. View

Raiskup F, Spoerl E . Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf. 2013; 11(2):65-74. DOI: 10.1016/j.jtos.2013.01.002. View

Bharathi M, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M . Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007; 14(2):61-9. DOI: 10.1080/09286580601001347. View

10.

Fernandes M, Sharma S . Polymicrobial and microsporidial keratitis in a patient using Boston scleral contact lens for Sjogren's syndrome and ocular cicatricial pemphigoid. Cont Lens Anterior Eye. 2012; 36(2):95-7. DOI: 10.1016/j.clae.2012.10.082. View

11.

Mamalis N . The increasing problem of antibiotic resistance. J Cataract Refract Surg. 2007; 33(11):1831-2. DOI: 10.1016/j.jcrs.2007.09.005. View

12.

Saglk A, Ucakhan O, Kanpolat A . Ultraviolet A and riboflavin therapy as an adjunct in corneal ulcer refractory to medical treatment. Eye Contact Lens. 2013; 39(6):413-5. DOI: 10.1097/ICL.0b013e3182960fdf. View

13.

Mattila J, Korsback A, Krootila K, Holopainen J . Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation. Acta Ophthalmol. 2013; 91(5):e410-1. DOI: 10.1111/aos.12115. View

14.

Iseli H, Thiel M, Hafezi F, Kampmeier J, Seiler T . Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008; 27(5):590-4. DOI: 10.1097/ICO.0b013e318169d698. View

15.

Martins S, Combs J, Noguera G, Camacho W, Wittmann P, Walther R . Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008; 49(8):3402-8. DOI: 10.1167/iovs.07-1592. View

16.

Lin A, Rhee M, Akpek E, Amescua G, Farid M, Garcia-Ferrer F . Bacterial Keratitis Preferred Practice Pattern®. Ophthalmology. 2018; 126(1):P1-P55. DOI: 10.1016/j.ophtha.2018.10.018. View

17.

Knyazer B, Krakauer Y, Baumfeld Y, Lifshitz T, Kling S, Hafezi F . Accelerated Corneal Cross-Linking With Photoactivated Chromophore for Moderate Therapy-Resistant Infectious Keratitis. Cornea. 2018; 37(4):528-531. DOI: 10.1097/ICO.0000000000001498. View

18.

Tabibian D, Richoz O, Hafezi F . PACK-CXL: Corneal Cross-linking for Treatment of Infectious Keratitis. J Ophthalmic Vis Res. 2015; 10(1):77-80. PMC: 4424723. DOI: 10.4103/2008-322X.156122. View

19.

Sorkhabi R, Sedgipoor M, Mahdavifard A . Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol. 2012; 33(1):61-6. DOI: 10.1007/s10792-012-9633-2. View

20.

Ting D, Henein C, Said D, Dua H . Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis. Ocul Surf. 2019; 17(4):624-634. DOI: 10.1016/j.jtos.2019.08.006. View